| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.46B | 15.63B | 16.13B | 13.67B | 17.54B | 14.43B |
| Gross Profit | 7.52B | 7.06B | 7.35B | 5.90B | 11.04B | 7.08B |
| EBITDA | 1.91B | 1.67B | 2.15B | 1.01B | 6.28B | 2.19B |
| Net Income | 1.55B | 1.19B | 1.57B | 623.20M | 4.76B | 1.58B |
Balance Sheet | ||||||
| Total Assets | 332.70B | 341.38B | 313.66B | 305.05B | 303.00B | 304.66B |
| Cash, Cash Equivalents and Short-Term Investments | 4.05B | 33.49B | 73.49B | 71.22B | 67.74B | 80.91B |
| Total Debt | 3.95B | 3.95B | 4.11B | 3.99B | 4.08B | 4.69B |
| Total Liabilities | 320.31B | 328.99B | 302.19B | 293.84B | 292.70B | 288.20B |
| Stockholders Equity | 11.82B | 11.88B | 11.09B | 10.92B | 10.00B | 16.07B |
Cash Flow | ||||||
| Free Cash Flow | 3.63B | 4.44B | 4.53B | 3.69B | 3.06B | 3.09B |
| Operating Cash Flow | 3.75B | 4.54B | 4.60B | 3.79B | 3.17B | 3.22B |
| Investing Cash Flow | -4.15B | -4.14B | -5.40B | -1.35B | 1.06B | -5.66B |
| Financing Cash Flow | 578.00M | -181.80M | 300.30M | -2.59B | -1.72B | 1.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $37.50B | 10.99 | 22.01% | 1.55% | 6.90% | 41.67% | |
73 Outperform | $21.80B | 12.02 | 13.35% | 3.44% | -1.98% | 48.93% | |
73 Outperform | $33.65B | 8.24 | 21.07% | ― | 8.66% | 32.96% | |
71 Outperform | $40.13B | ― | 7.50% | 2.02% | -24.08% | 26.42% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $12.30B | 10.92 | 11.63% | 5.77% | 33.06% | 50.47% | |
50 Neutral | $11.88B | 15.82 | -152.32% | 2.15% | -16.14% | -224.34% |